Effect of Early Mechanical Ventilation to Severe Acute Pancreatitis

November 18, 2013 updated by: Erzhen Chen, Ruijin Hospital
Acute lung injury (ALI) and acute respiratory distress syndrome(ARDS) represent the most common and earliest organ dysfunction in acute pancreatitis, presenting as dyspnea and intractable hypoxemia, with secondary bilateral pulmonary infiltrates on radiograph. And mechanical ventilation (MV) is the essential intervention to improve oxygenation. When to initiate MV remains uncertain. In this study, we aim to compare the effect of early MV and conventional MV, and we hypothesize that early MV may be a better treatment option.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Enqiang MAO, MD
  • Phone Number: 86-13501747906

Study Locations

      • Shanghai, China, 200025
        • Recruiting
        • Department of EICU, Ruijin Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of pancreatitis:typical pain, increase in serum lipase or amylase, onset of abdominal pain within 72h before admission
  • The diagnosis criteria of Severe Acute Pancreatitis is according to Atlanta criteria revisited in 2012
  • the diagnosis of ARDS meets the criteria of Berlin definition

Exclusion Criteria:

  • chronic respiratory disease as chronic obstructive pulmonary disease (COPD), asthma
  • organic cardiopathy
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: early mechanical ventilation

Fulfillment of three or more criteria below:

respiratory rate > 28 per minute serum lactate > 3 mmol/L PaO2/FiO2 Index <300 mmHg SvO2 < 65% lung infiltration or atelectasis, pleural exudation

Abbreivation: PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; SvO2, venous oxygen saturation

Fulfillment of three or more criteria below:

respiratory rate > 28 per minute serum lactate > 3 mmol/L PaO2/FiO2 Index <300 mmHg SvO2 < 65% lung infiltration or atelectasis, pleural exudation

Experimental: conventional mechanical ventilation
other group who don't start early mechanical ventilation and fulfillment four criteria below: respiratory rate > 28 bpm dyspnea PaO2/FiO2 Index <200 mmHg Chest X-ray: lung infiltration exclude chronic heart failure and pulmonary disease
other group who don't start early mechanical ventilation and fulfillment four criteria below: respiratory rate > 28 bpm dyspnea PaO2/FiO2 Index <200 mmHg Chest X-ray: lung infiltration exclude chronic heart failure and pulmonary disease

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mechanical Ventilation Time
Time Frame: 28 days
28 days

Secondary Outcome Measures

Outcome Measure
Time Frame
the incidence of ventilation associated pneumonia
Time Frame: 28 days
28 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: 60 days
60 days
the incidence other complications of mechanical ventilation
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 months
patient-mechanic desynchronization, pneumothorax, atelectasis
participants will be followed for the duration of hospital stay, an expected average of 2 months
hospital stay
Time Frame: the participants will be followed till the discharge, an expected average of 2 months
the participants will be followed till the discharge, an expected average of 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Anticipated)

June 1, 2015

Study Completion (Anticipated)

June 1, 2016

Study Registration Dates

First Submitted

November 6, 2013

First Submitted That Met QC Criteria

November 18, 2013

First Posted (Estimate)

November 25, 2013

Study Record Updates

Last Update Posted (Estimate)

November 25, 2013

Last Update Submitted That Met QC Criteria

November 18, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • SAP bundle -- MV
  • 12411950500 (Other Grant/Funding Number: Science and Technology Commission of Shanghai Municipality)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis

Clinical Trials on early mechanical Ventilation

3
Subscribe